[1] 王磊,于丽萍,窦科峰.内毒素致枯否细胞中NF-κB的激活及其意义[J].宁夏医学院报,2003,25(4):239-241.
[2] MORRISON D S,RYAN J C.Endotoxin and disease mechanism[J].Annual Review of Medicine,1987,38:417-432.
[3] 毕铭华,张淑文,王宝恩,等.内毒素血症对大鼠肝细胞线粒体的损伤及其机制[J].中国应用生理学杂志,2004,20(1):90-92.
[4] 董宇杰,丁春华,张智,等.褪黑素对内毒素致大鼠急性肺损伤的保护作用[J].中国应用生理学杂志,2010,26(4):481-484.
[5] 郭德玉,谯怡然.内毒素介导的肾脏病变及其发生机理的实验研究[J].临床与实验病理学杂志,1995,11(3):226-229.
[6] NRC.Nutrient requirements of small ruminants:sheep,goats,cervids and New World camelids[S].Washington,D.C.:National Academy Press,2007.
[7] DOW T L,ROGERS-NIEMAN G,HOLÁSKOVÁ I,et al.Tumor necrosis factor-α and acute-phase proteins in early pregnant ewes after challenge with peptidoglycan-polysaccharide[J].Domestic Animal Endocrinology,2010,39:147-154.
[8] 郑瑞丹,徐成润.脂多糖/脂多糖结合蛋白与杀菌通透性增进行蛋白研究进展[J].临床军医杂志,2007.35(6):933-936.
[9] SCHRODER N W,SCHUMANN R R.Non-LPS targets and actions of LPS binding protein(LBP)[J].Journal of Endotoxin Research,2005,11(4):237-242.
[10] AZUMA M,MATSUO A,FUJIMOTO Y,et al.Inhibition of lipid A2 mediated type Ⅰ interferon induction by bactericidal/permeability-increasing protein (BFI)[J].Biochemical Biophysical Research Community,2007,354(2):574-578.

[11] 査锡良,周春燕,周爱儒,等.生物化学[M].北京:人民卫生出版社,2008:409.
[12] 郑晓丰.m-AST、RBP、PA、ADA和FN在肝脏疾病诊断中的临床评价[J].检验医学,2009,24(12):886-888.
[13] 康格非.临床生物化学与生物化学检验[M].2版.北京:人民卫生出版社,1999:166.
[14] HASANJANI-ROUSHAN M R,HAJIAHMADI M,SHAFAIE S.Histopathological features of liver and its relation to serum transaminase levels in 91 cases of anti-HBe-positive chronic hepatitis B[J].The International Journal of Clinical Practice,2005,59(7):79l-794.
[15] 朱永芬,田德英.内毒素对SD大鼠急性肝功能衰竭模型血糖代谢影响的研究[J].内科急危重症杂志,2006,12:119-121.
[16] JANICE J,STEVE S C,ANNA M D.Mechanisms of disease progression in nonalcoholic fatty liver disease[J].Seminar in Liver Disease,2008,28(4):370-379.

[17] KENT D,ASADA L,PETER S T,et al.Animal models of sepsis and sepsis-induced kidney injury[J].The Journal of Clinical Investigation,2009,119(10):2868-2878.

[18] 章蔚,方才,言虎.不同剂量6%羟乙基淀粉130/0.4预先给药对大鼠内毒素性急性肾损伤的影响[J].安徽医科大学学报,2007,42(6):672-675.
[19] 李生,吴万春.内毒素与脂肪肝的关系研究进展[J].国际消化病杂志,2007,27(3):205-207.
[20] YOSHIMATSU M,TERASAKI Y,SAKASHITA N,et a1.Induction of macrophage scavenger receptor M ARCO in nonalcoholic steato-hepatitis indicates possible involvement of endotoxin in its path-ogenic process[J].International Journal of Experimental Pathology,2004,85:335-343.
[21] FABBRINI E,SULLIVAN S,KLEIN S.Obesity and nonalcoholic fatty liver disease:biochemical,metabolic,and clinical implications[J].Hepatology,2010,51:679-689.
[22] 叶强,雷寒.内毒素、炎症与脂质代谢紊乱的研究进展[J].心血管病学进展,2008,29(5):782-784.
[23] RUAN X Z,MOORHEAD J F,FERNADO R. Regulation of lipoprotein trafficking in the kidney role of inflammatory mediators and transcription factors[J].Biochemical Society Transactions,2004,32:88-91.
[24] CASTRILLO A,JOSEPH S B,VAIDYA S A.Crosstalk between LXR and toll-like receptor signaling mediates bacterial and viral antagonism of cholesterol metabolism[J].Molecular Cell,2003,12:805-816.
[25] 张娜,赵斐,张勇.有氧运动改善高脂血症分子机理的研究Ⅲ.运动上调饮食性高胆固醇血症大鼠肝脏
LCAT和
apoAI基因表达[J].中国运动医学杂志,2001,20(3):232-235.
[26] LEVELS J H,AHRAHAM P R,VANDEN E A,et al.Distribution and kinetics of lipoprotein-bound endotoxin[J].Infection and Immunity,2001,69(5):2821-2828.